Furthermore, survival analysis demonstrated that similarly to the expression of CXCL6 and CXCR2, the high expression of CD163 negatively affected the overall survival of patients with HCC (Figure 2C). This evidence concerns the gene CXCL6 and hepatocellular carcinoma.